Localized Alveolar Ridge Augmentation With Dental Implant (RidgeDI)
An Open Label, Non-randomized, Single-arm, Multi-center Study to Assess Localized Alveolar Ridge Augmentation Utilizing INFUSE® Bone Graft Concurrent With Dental Implant Placement
Sponsor: Averion International Corporation
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Averion International Corporation
More terminations from Averion International Corporation
Other Alveolar Bone Loss trials with similar outcome
This observational or N/A phase trial investigates Alveolar Bone Loss and is currently terminated or withdrawn. Averion International Corporation leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Averion International Corporation
- Medtronic Spinal and Biologics
For direct contact, visit the study record on ClinicalTrials.gov .